A Path to Precision Metabolic Treatment in Breast Cancer: Riluzole, Glutamate Signaling, and Invasive Lobular Carcinoma
Author:
Affiliation:
1. Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
2. Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical School, Minneapolis, MN 55455, USA
Funder
Office of the Assistant Secretary of Defense for Health Affairs
Department of Defense
Publisher
The Endocrine Society
Subject
Endocrinology, Diabetes and Metabolism
Link
https://academic.oup.com/jes/advance-article-pdf/doi/10.1210/jendso/bvad171/54876962/bvad171.pdf
Reference8 articles.
1. Head-to-head evaluation of 18F-FES and 18F-FDG PET/CT in metastatic invasive lobular breast cancer;Ulaner;J Nucl Med,2021
2. Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer;Olukoya;J Endocr Soc,2023
3. Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism;Du;Sci Rep,2018
4. Expression of metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma;Kim;Tumour Biol,2014
5. Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer;Du;Breast Cancer Res,2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3